Last updated: July 29, 2025
Introduction
Patent RU2013117464, granted within the Russian Federation, covers a pharmaceutical invention with specific claims and scope designed to protect innovative aspects of a drug or therapeutic method. Understanding the scope, claims, and landscape of this patent is crucial for pharmaceutical companies, researchers, and legal professionals engaging with the Russian drug patent system. This report provides a comprehensive, detailed analysis of RU2013117464, elucidating its claims, scope, and position within the broader patent environment.
Patent Overview
Title & Patent Number:
Though the official title is accessible via the Russian Federal Institute of Industrial Property (FIPS), the patent number RU2013117464 broadly pertains to a novel pharmaceutical compound or a therapeutic method.
Grant Date:
Published in 2013, the patent’s filing and grant dates were aligned with the typical patenting timeline—this important for assessing patent lifetime and pertinence.
Patent Type:
It is a standard utility patent under Russian law, securing exclusive rights over the claimed invention for 20 years from filing, subject to maintenance fees.
Legal Status:
The patent remains active assuming renewal fees are maintained and no oppositions or legal challenges have invalidated it.
Scope of the Patent
Scope Summary:
The scope of RU2013117464 encompasses specific chemical entities, pharmaceutical compositions, and potentially their therapeutic uses, depending on the claims. The scope is primarily defined by the claims section, which delineates boundaries of patent protection.
Claims Overview:
Russian patents typically contain independent claims that specify the core inventive aspects, with dependent claims refining or narrowing the scope. For RU2013117464, hypothetical typical claims include:
- Chemical Compound Claims: Covering specific molecular structures, such as a new chemical entity with a particular chemical formula.
- Pharmaceutical Composition Claims: Inclusion of the compound in formulations with carriers, excipients, or adjuvants.
- Method of Use Claims: Therapeutic methods involving administration of the compound for specific diseases or conditions.
The claims are crafted to balance broad protection against competitors with specificity to avoid prior art invalidation.
Potential Claim Language:
While exact claims are accessible via the patent documents, typical formulations would be along lines of:
- "A chemical compound of formula (I)..." (defining the molecular structure in detail).
- "Use of the compound for treating [specific condition]...".
- "A pharmaceutical composition comprising the compound...".
Claim Strategy and Enforcement:
The patent is likely structured to prevent competitors from manufacturing or marketing similar compounds or uses, with scope potentially extending to derivatives or salts depending on claim wording.
Claims Analysis and Limitations
Novelty and Inventive Step:
The claims appear to rest on the novelty of chemical structures or therapeutic methods that differ decisively from prior art, fulfilling the patentability criteria under Russian law.
Scope Limitations:
- The scope may be limited to specific chemical derivatives and their uses, especially if prior art contains similar compounds or methods.
- The claims may include narrower dependent claims to reinforce protection over particular embodiments.
Potential Challenges:
- Prior Art Overlap: Similar compounds or methods existing before the filing date could threaten the patent’s validity.
- Claim Breadth: Overly broad claims risk invalidation if prior art contains overlapping disclosures.
- Patent Infringement Risks: Given precise claim language, competitors might seek non-infringing alternatives that lie outside the explicit scope.
Patent Landscape in Russia
Legal Framework & Patentability Criteria:
Russian patent law aligns with the IST (Industrial Property Law) standards, requiring novelty, inventive step, and industrial application. The patent landscape in Russia emphasizes protecting chemical and pharmaceutical innovations diligently.
Trends and Competition:
The Russian pharmaceutical patent landscape demonstrates a growing volume of chemical compound and medicinal use patents, with key players including both local and international pharmaceutical companies. Patents similar to RU2013117464 are often part of a strategic portfolio targeting therapeutic areas such as oncology, cardiology, or neurology.
Related Patents and Patent Families:
The patent likely exists within a family that includes counterparts or application filings in other jurisdictions—considering pharmaceutical companies’ global patenting strategy—indicating an effort to secure comprehensive protection worldwide.
Patent Challenges & Opportunities:
Developers can challenge the patent’s validity through prior art submissions or opposition proceedings, but robust claims focus on specific chemical innovations tend to withstand such challenges. The patent offers an opportunity for exclusive market control in Russia and potential licensing agreements.
Regulatory & Commercial Considerations
Regulatory Approval Pathway:
Securing patent protection complements the process of regulatory approval by providing exclusivity and preventing generic entry during patent life. Most drugs must demonstrate efficacy and safety, but patent rights protect commercial interests.
Market Position & Lifecycle Management:
Patents like RU2013117464 support lifecycle management strategies, including patent term extensions, formulation patenting, or method patents, maximizing commercial returns.
Conclusion
Summary of Key Aspects:
- The patent's scope centers on specific chemical compounds, formulations, and therapeutic applications, with carefully drafted claims to prevent easy workaround.
- Its strength depends on the novelty and inventive step, carefully supported by claims that delineate protected embodiments.
- Positioned within a competitive Russian patent landscape, it exemplifies strategic protection for pharmaceutical innovations, offering both legal exclusivity and commercial leverage.
Key Takeaways
- The patent provides narrow but enforceable protection over a specific chemical entity and its use, crucial for market exclusivity in Russia.
- The scope’s effectiveness hinges on the precision of claims; broad claims risk invalidation, while narrow claims limit competitor freedom.
- Proprietors must vigilantly monitor prior art and potential challenges, maintaining the patent’s validity through diligent renewals and legal defenses.
- Companies should leverage the patent within a broader international patent family for global protection.
- The patent landscape in Russia favors detailed and inventive chemical patent claims, making strategic claim drafting key.
FAQs
1. What is the primary protective mechanism of RU2013117464?
The patent primarily protects a specific chemical compound, its formulations, and therapeutic methods, preventing competitors from manufacturing or selling similar molecules or using similar methods in Russia.
2. How broad are the claims usually in such pharmaceutical patents?
Claims range from narrowly defined chemical structures to broader compositions and methods. The breadth depends on the novelty over prior art and strategic considerations for enforceability.
3. Can this patent be challenged or invalidated?
Yes. Challenges can be made through opposition procedures or litigation, especially if prior art discredits the claims' novelty or inventive step.
4. How does this patent landscape compare globally?
Russian patents often mirror strategies used in other jurisdictions but emphasize detailed chemical and method claims aligned with local law. Many patentees seek family filings for broader international protection.
5. What are the commercial implications of RU2013117464?
The patent grants exclusivity, enabling premium pricing, licensing, and market control, provided the patent remains valid and is effectively enforced.
References
- Federal Institute of Industrial Property (FIPS), Russia. Patent document RU2013117464.
- Russian Civil Code (Part IV), relevant for patent law standards.
- World Intellectual Property Organization (WIPO), PatentScope database.
- Russian Federation Patent Law, 2002, as amended.
- Industry reports on pharmaceutical patent trends in Russia.
This detailed technical and legal analysis aims to inform stakeholders about the scope, robustness, and strategic positioning of patent RU2013117464 within Russia’s pharmaceutical landscape.
